CAN/CSA-Z9360-2-07: Technical Requirements for Heat and Moisture Exchangers for Tracheostomized Patients

Introduction and Scope of CAN/CSA-Z9360-2-07

The standard CAN/CSA-Z9360-2-07 (ISO 9360-2:2001 IDT) is the Canadian national adoption of the International Standard for Heat and Moisture Exchangers (HMEs) used specifically for tracheostomized patients with minimal tidal volumes. As a Category ‘Z’ standard under the CSA Group umbrella, this standard closes a critical gap in respiratory care. While Part 1 of the series addresses HMEs for general use, Part 2 focuses entirely on the delicate respiratory mechanics of patients whose upper airways are bypassed and whose tidal volumes may be as low as 50 mL, typical of neonatal and pediatric intensive care.

Clinical Significance: For a neonate with a tidal volume of 50 mL, an HME that merely meets general standards could inadvertently impose a significant burden. An improperly designed device can increase dead space, leading to CO₂ rebreathing, or add resistance, dramatically increasing the work of breathing. CAN/CSA-Z9360-2-07 explicitly mitigates these risks through strict performance thresholds.

The scope explicitly covers HMEs placed between a tracheostomy tube and the breathing system. It applies to devices that may integrate additional features, such as heat sinks or filtration media (HMEFs). It sets forth mandatory parameters for design, performance testing, labeling, and packaging to ensure safe use in extremely vulnerable patients.

Core Technical Requirements and Performance Metrics

CAN/CSA-Z9360-2-07 mandates rigorous test methods that replicate the extreme conditions of low-volume ventilation. The core focus is on three critical parameters: Moisture Output, Dead Space, and Resistance.

Moisture Output Performance

The primary function of an HME is to conserve heat and moisture. The standard specifies a minimum moisture output in mg/L under standardized test conditions. The test rig delivers gas at a specific humidity (>95% RH) and temperature (23°C) at a specified tidal volume and respiratory rate. For the smallest devices, this requires highly efficient hygroscopic media to capture and return sufficient water vapor.

Dead Space Management

Physical dead space is the internal volume of the HME that recycles exhaled air. For a patient with a tidal volume of 50 mL, every milliliter of dead space reduces the effective alveolar ventilation. The standard therefore imposes strict limits on the internal volume of the device, forcing manufacturers towards low-profile designs.

Technical Challenge: There is an inverse relationship between dead space and moisture output. A larger media surface area captures more moisture but often increases internal volume and resistance. CAN/CSA-Z9360-2-07 demands optimization of these trade-offs, requiring sophisticated engineering of the hygroscopic or hydrophobic media to satisfy all constraints simultaneously.

Resistance to Gas Flow

The pressure drop across the HME must remain exceptionally low, measured at specific flow rates (e.g., 1 L/min and 5 L/min) to ensure the device does not impede the ventilator’s ability to deliver the prescribed breath or trigger a breath in spontaneously breathing patients.

Performance Parameter	Test Condition	Requirement
Minimum Moisture Output	50 mL tidal volume, 20 bpm	≥ 33 mg/L
Maximum Internal Dead Space	Geometric volume calculation	≤ 2 mL
Pressure Drop @ 1 L/min	Constant flow	≤ 0.2 kPa
Pressure Drop @ 5 L/min	Constant flow	≤ 0.8 kPa
Blockage Resistance	Water exposure test	No occlusion

Design Optimization: Modern HMEs integrating a viral filter and an electrostatic medium can achieve the humidity performance required by Z9360-2-07 while simultaneously meeting stringent filtration standards. This multi-functional design is the gold standard in critical care for providing both protection and optimal airway conditioning.

Compliance, Verification, and Regulatory Landscape

CAN/CSA-Z9360-2-07 is harmonized with Health Canada’s expectations for Class II medical devices. Compliance is a strong indicator of due diligence for Medical Device Licence (MDL) applications.

Testing and Certification Protocol

To claim compliance, manufacturers typically engage a third-party testing body like the CSA Group itself. The evaluation covers:

Design and Technical File Review: Assessment of the risk management file (per ISO 14971), intended use, and design specifications.
Performance Testing: Rigorous bench testing of the device against all clauses in the standard, particularly the humidification and resistance tests under low tidal volume conditions.
Labeling and IFU: Verification of instructions for use, symbols, and clinical warnings to ensure unambiguous clinical guidance.

Regulatory Caution: CAN/CSA-Z9360-2-07 does not replace the requirements of the Canadian Medical Devices Regulations (SOR/98-282). Manufacturers must still comply with establishment licensing, MDL application procedures, and post-market surveillance obligations. Compliance with the standard significantly strengthens an application, but it is not a blanket exemption.

Maintaining Compliance

The standard is a living requirement within the manufacturer’s quality system. Any change in manufacturing location, material sourcing, or production process requires a re-evaluation to ensure the device continues to meet the performance metrics confirmed at initial certification. Version control and document management are critical for long-term conformity.

Frequently Asked Questions (FAQ)

Q: What is the primary clinical distinction between CAN/CSA-Z9360-2-07 and the general standard for HMEs (Part 1)?
A: Part 2 is specifically designed for tracheostomized patients with minimal tidal volumes, typically neonates and infants (Vt as low as 50 mL), where small changes in dead space or resistance significantly impact gas exchange. Part 1 applies to patients with tidal volumes greater than 250 mL who typically breathe through their upper airways.

Q: Does CAN/CSA-Z9360-2-07 cover standards for bacterial/viral filtration in HMEFs?
A: The standard’s primary focus is humidification. If a device claims filtration capabilities (HMEF), its filtration efficiency must be validated against separate recognized standards (e.g., ASTM F2101 for bacterial filtration, ASTM F2299 for viral filtration) and must not compromise the HME functions mandated by Z9360-2-07.

Q: What are the consequences of using an HME non-compliant with this standard on a neonatal patient?
A: A non-compliant HME poses risks of inadequate humidification (mucosal damage, impaired ciliary function, airway obstruction), excessive dead space (hypercapnia, respiratory distress), and high resistance (increased work of breathing, ventilator dyssynchrony). CAN/CSA-Z9360-2-07 specifically mitigates these risks for low-volume patients.

📥 Standard Documents Download

🔒

Please wait 10 seconds, the download links will appear after the ad loads